Ubs Group Ag Harvard Bioscience Inc Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Ubs Group Ag holds 20,722 shares of HBIO stock, worth $44,966. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,722

Previous 13,856 49.55%

Holding current value

$44,966

Previous $39,000 41.03%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.64 - $3.54 $18,126 - $24,305	6,866 Added 49.55%	20,722 $55,000
Q2 2024 Aug 13, 2024	SELL	$2.77 - $4.63 $74,438 - $124,421	-26,873 Reduced 65.98%	13,856 $39,000
Q1 2024 May 13, 2024	SELL	$4.02 - $5.39 $23,496 - $31,504	-5,845 Reduced 12.55%	40,729 $172,000
Q4 2023 Feb 09, 2024	BUY	$4.0 - $5.49 $105,212 - $144,403	26,303 Added 129.76%	46,574 $249,000
Q3 2023 Nov 09, 2023	SELL	$4.0 - $5.82 $26,468 - $38,510	-6,617 Reduced 24.61%	20,271 $87,000
Q2 2023 Aug 11, 2023	BUY	$4.19 - $6.16 $97,920 - $143,959	23,370 Added 664.3%	26,888 $147,000
Q1 2023 May 12, 2023	SELL	$2.45 - $4.22 $3,302 - $5,688	-1,348 Reduced 27.7%	3,518 $14,000
Q4 2022 Feb 08, 2023	BUY	$2.12 - $2.86 $4,403 - $5,940	2,077 Added 74.47%	4,866 $13,000
Q3 2022 Nov 10, 2022	BUY	$2.33 - $3.92 $5,056 - $8,506	2,170 Added 350.57%	2,789 $7,000
Q2 2022 Aug 10, 2022	SELL	$3.28 - $6.42 $8,140 - $15,934	-2,482 Reduced 80.04%	619 $2,000
Q1 2022 May 16, 2022	SELL	$5.16 - $7.14 $39,288 - $54,363	-7,614 Reduced 71.06%	3,101 $19,000
Q4 2021 Feb 14, 2022	BUY	$6.37 - $8.18 $47,660 - $61,202	7,482 Added 231.43%	10,715 $75,000
Q3 2021 Nov 15, 2021	BUY	$6.98 - $8.47 $20,088 - $24,376	2,878 Added 810.7%	3,233 $23,000
Q2 2021 Aug 13, 2021	SELL	$5.44 - $8.4 $28,712 - $44,335	-5,278 Reduced 93.7%	355 $3,000
Q1 2021 May 12, 2021	SELL	$3.91 - $6.99 $12,969 - $23,185	-3,317 Reduced 37.06%	5,633 $31,000
Q4 2020 Feb 11, 2021	BUY	$3.0 - $4.5 $23,685 - $35,527	7,895 Added 748.34%	8,950 $38,000
Q3 2020 Nov 12, 2020	SELL	$2.75 - $4.2 $31,308 - $47,817	-11,385 Reduced 91.52%	1,055 $3,000
Q2 2020 Jul 31, 2020	BUY	$2.12 - $3.14 $26,251 - $38,882	12,383 Added 21724.56%	12,440 $39,000
Q1 2020 May 01, 2020	SELL	$1.42 - $3.29 $4,204 - $9,741	-2,961 Reduced 98.11%	57 $0
Q4 2019 Feb 14, 2020	SELL	$2.45 - $3.25 $1,396 - $1,852	-570 Reduced 15.89%	3,018 $9,000
Q3 2019 Nov 14, 2019	SELL	$1.59 - $3.47 $1,715 - $3,744	-1,079 Reduced 23.12%	3,588 $11,000
Q2 2019 Aug 14, 2019	BUY	$1.93 - $4.59 $7,077 - $16,831	3,667 Added 366.7%	4,667 $9,000
Q1 2019 May 14, 2019	SELL	$2.77 - $4.38 $38,065 - $60,189	-13,742 Reduced 93.22%	1,000 $4,000
Q4 2018 Feb 14, 2019	SELL	$3.03 - $5.0 $3,896 - $6,430	-1,286 Reduced 8.02%	14,742 $47,000
Q3 2018 Nov 14, 2018	BUY	$5.0 - $6.65 $47,210 - $62,789	9,442 Added 143.36%	16,028 $85,000
Q2 2018 Aug 14, 2018	BUY	$4.2 - $5.95 $24,511 - $34,724	5,836 Added 778.13%	6,586 $36,000
Q1 2018 May 15, 2018	SELL	$3.3 - $5.15 $3,534 - $5,515	-1,071 Reduced 58.81%	750 $4,000
Q4 2017 Feb 14, 2018	BUY	$3.08 - $3.8 $27 - $34	9 Added 0.5%	1,821 $6,000
Q3 2017 Nov 14, 2017	SELL	$2.7 - $3.75 $5,013 - $6,963	-1,857 Reduced 50.61%	1,812 $7,000
Q2 2017 Aug 14, 2017	SELL	N/A	-541 Reduced 12.85%	3,669 $9,000
Q1 2017 Nov 14, 2017	BUY	N/A	4,210	4,210 $11,000

Others Institutions Holding HBIO

# of Institutions

Shares Held

31.5M

Call Options Held

700

Put Options Held

2.1K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account